Latest Articles

Subject

Article Type

You have access
Reversal of direct oral anticoagulants: Highlights from the Anticoagulation Forum guideline
Haeshik S. Gorr, MD, Lucy Yun Lu, PharmD, MS and Eric Hung, PharmD, CACP, AE-C

Cleveland Clinic Journal of Medicine February 2021, 88 (2) 98-103; DOI: https://doi.org/10.3949/ccjm.88a.19133

Clear instructions on how to manage DOAC-associated bleeding.
You have access
Cardiac surveillance for anti-HER2 chemotherapy
Patrick Collier, MD, PhD, FASE, FESC, FACC, Muzna Hussain, MD, Zoran B. Popovic, MD, PhD and Brian P. Griffin, MD

Cleveland Clinic Journal of Medicine February 2021, 88 (2) 110-116; DOI: https://doi.org/10.3949/ccjm.88a.19150

A more focused approach is advocated.
You have access
Precision treatment for metastatic non–small cell lung cancer: A conceptual overview
Tristan Lee, MD, Jeffrey M. Clarke, MD, Deepali Jain, MD, Sendhilnathan Ramalingam, MD and Vishal Vashistha, MD

Cleveland Clinic Journal of Medicine February 2021, 88 (2) 117-127; DOI: https://doi.org/10.3949/ccjm.88a.19148

Targeted therapy has revolutionized treatment of patients with advanced solid tumors.
You have access
A 21-year-old woman with Ehlers-Danlos syndrome and persistent lightheadedness
Raed Qarajeh, MD, Laith A. Derbas, MD, Mouin Abdallah, MD, MSc and Faraz Kureshi, MD, MSc

Cleveland Clinic Journal of Medicine February 2021, 88 (2) 93-97; DOI: https://doi.org/10.3949/ccjm.88a.19137

She has a long history of lightheadedness upon standing, and it is getting worse.
You have access
How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
Wendy O. Henderson, MD, Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP and Bryan C. Batch, MD, MHS

Cleveland Clinic Journal of Medicine February 2021, 88 (2) 81-85; DOI: https://doi.org/10.3949/ccjm.88a.19135

Hemoglobin A1c is the standard but is not perfect. Alternatives are available.
You have access
The role of SGLT-2 inhibitors in managing type 2 diabetes
Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

These drugs improve glycemic control and offer cardiovascular and metabolic benefits.
You have access
SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

Randomized controlled trials of these new agents had positive outcomes.
You have access
A patient with breast cancer and a rash on her hands and feet
Jonathan Stewart, BS, Grace U. Salacup, MD and Kevin Bryan Uy Lo, MD

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 22-23; DOI: https://doi.org/10.3949/ccjm.88a.20020

She had completed her third cycle of chemotherapy 3 days earlier.
You have access
Prescribing testosterone and DHEA: The role of androgens in women
Taryn Smith, MD, NCMP and Pelin Batur, MD, FACP, NCMP

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 35-43; DOI: https://doi.org/10.3949/ccjm.88a.20030

Androgens play an important physiologic role and can promote sexual health.
You have access
Trials and tribulations of testosterone therapy in women: Importance of adhering to the evidence
Juliana M. Kling, MD, MPH, NCMP, FACP and Sharon J. Parish, MD

Cleveland Clinic Journal of Medicine January 2021, 88 (1) 44-46; DOI: https://doi.org/10.3949/ccjm.88a.20195

Testosterone should not be touted for outcomes that are not supported by data.

Main menu

User menu

Search

Latest Articles

Pages

Navigate

Authors & Reviewers